HOWL Werewolf Therapeutics, Inc. - Common Stock
$0,41
Harga · Agu 19, 2026
Fundamental per Jul 31, 2026
Rentang 52M
$0–$2
7% of range
Peringkat Analis
STRONG BUY
10 analysts
Target Harga
$7
+1602% upside
P/E (TTM)
-0.3
ROE
-183.6%
Margin Laba Bersih
—
HOWL Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$0.41
Kapitalisasi Pasar
$20M
P/E (TTM)
-0.3
EPS (TTM)
$-1.33
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
-183.6%
D/E Utang/Ekuitas
1.1
Rentang 52M
$0 – $2
HOWL Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
$-1.33
2020-12-31
→
2025-12-31
Arus Kas Bebas
$-60M
2021-12-31
→
2025-12-31
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
HOWL
Median Rekan
P/E (TTM)
-0.3
—
P/B
0.8
3.3
EV / EBITDA
0.1
—
Price / FCF (Harga / FCF)
-0.3
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
HOWL
Median Rekan
ROA
-62.0%
-66.0%
ROE
-183.6%
-128.2%
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
HOWL
Median Rekan
Debt / Equity (Utang / Ekuitas)
1.1
1.0
Current Ratio (Rasio Lancar)
1.6
2.6
Quick Ratio (Rasio Cepat)
1.6
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
HOWL
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
HOWL
Median Rekan
HOWL Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
10 analis
- Beli Kuat 4 40,0%
- Beli 4 40,0%
- Tahan 2 20,0%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
1 analis · 2026-08-18
Rendah
$7.00
Tinggi
$7.00
Target median
$7.00
+1601,5%
Target rata-rata
$7.00
+1601,5%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.09%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 30 Juni 2026 | $0.08 | $-0.27 | 0.35% |
| 31 Maret 2026 | $-0.28 | $-0.29 | 0.01% |
| 31 Des. 2025 | $-0.17 | $-0.35 | 0.18% |
| 30 Sep. 2025 | $-0.36 | $-0.40 | 0.04% |
| 30 Juni 2025 | $-0.40 | $-0.49 | 0.09% |
| 31 Maret 2025 | $-0.40 | $-0.40 | 0.00% |
| 31 Des. 2024 | $-0.46 | $-0.43 | -0.03% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| HOWL | $31M | -0.5 | — | — | -183.6% | — |
| NEUP | $14M | -30.9 | — | -2.4% | -2.3% | — |
| CELU | $32M | -0.3 | -51.0% | -345.4% | 288.6% | — |
| CLRB | — | -0.4 | — | — | — | — |
| MRKR | $25M | -1.9 | -46.2% | -343.0% | -89.1% | — |
| SKYE | $25M | -0.5 | — | — | -175.6% | — |
| KALA | $15M | -0.2 | — | — | -1423.8% | — |
| CYCN | — | -1.1 | 3.7% | — | — | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 14
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $45M | $56M | $42M | $54M | $35M | $17M | |
| SG&A Expense | $16M | $19M | $19M | $19M | $15M | $6M | |
| Operating Expenses | $61M | $75M | $60M | $72M | $50M | $22M | |
| Operating Income | $-61M | $-74M | $-41M | $-56M | $-50M | $-22M | |
| Interest Expense | · | · | $3M | $0 | · | · | |
| Interest Income | $3M | $7M | $7M | $2M | · | · | |
| Other Non-op | $2M | $2M | $-1M | $338.0K | $104.0K | $7M | |
| Income Tax | $0 | · | · | · | · | · | |
| Net Income | $-61M | $-71M | $-37M | $-54M | $-50M | $-15M | |
| EPS (Basic) | $-1.32 | $-1.63 | $-1.05 | $-1.86 | $-10.94 | $-28.08 | |
| EPS (Diluted) | $-1.33 | $-1.63 | $-1.05 | $-1.86 | $-10.94 | $-28.08 | |
| Shares (Basic) | 46,018,888 | 43,332,088 | 35,646,572 | 28,863,935 | 18,455,000 | 1,005,000 | |
| Shares (Diluted) | 46,810,252 | 43,859,664 | 35,646,572 | 28,863,935 | 18,455,000 | 1,005,000 | |
| EBITDA | $-61M | $-74M | $-41M | $-56M | $-50M | · |
Neraca 23
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $111M | $134M | $129M | $158M | $93M | |
| Prepaid Expense | $2M | $2M | $3M | $4M | $4M | $344.0K | |
| Current Assets | $59M | $113M | $138M | $140M | $161M | $93M | |
| PP&E (Net) | $5M | $6M | $8M | $9M | $3M | $651.0K | |
| PP&E (Gross) | $11M | $11M | $11M | $10M | $3M | $826.0K | |
| Accum. Depreciation | · | · | · | · | $391.0K | · | |
| Other Non-current Assets | $5.0K | $320.0K | $594.0K | $1M | $649.0K | $0 | |
| Total Assets | $69M | $127M | $175M | $160M | $179M | $96M | |
| Accounts Payable | $754.0K | $3M | $1M | $1M | $2M | $1M | |
| Accrued Liabilities | $5M | $11M | $9M | $14M | $9M | $4M | |
| Short-term Debt | $28M | $0 | $7M | $0 | · | · | |
| Current Liabilities | $36M | $15M | $19M | $24M | $12M | $5M | |
| Capital Leases | $8M | $9M | $11M | $13M | $15M | $2M | |
| Other Non-current Liabilities | · | · | $0 | $191.0K | $0 | $31.0K | |
| Total Liabilities | $45M | $54M | $63M | $38M | $26M | $7M | |
| Long-term Debt | $32M | $32M | $40M | · | · | · | |
| Total Debt | $28M | $0 | $7M | · | · | · | |
| Common Stock | $5.0K | $5.0K | $4.0K | $3.0K | $2.0K | $2.0K | |
| Paid-in Capital | $500M | $488M | $455M | $429M | $406M | $0 | |
| Retained Earnings | $-475M | $-415M | $-344M | $-307M | $-253M | $-52M | |
| Stockholders' Equity | $25M | $73M | $111M | $122M | $153M | $-52M | |
| Liabilities + Equity | $69M | $127M | $175M | $160M | $179M | $96M | |
| Shares Outstanding | 48,596,817 | 44,827,159 | 39,107,048 | 31,515,074 | 27,313,000 | 1,184,000 |
Arus Kas 10
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $9M | $8M | $7M | $4M | $632.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-60M | $-56M | $-33M | $-41M | $-43M | $-19M | |
| CapEx | $0 | $254.0K | $769.0K | $4M | $498.0K | $560.0K | |
| Investing Cash Flow | $0 | $-254.0K | $-769.0K | $-4M | $-498.0K | $-560.0K | |
| Stock Issued | $6M | $24M | $18M | $16M | $0 | · | |
| Net Stock Activity | $6M | $24M | $18M | $16M | · | · | |
| Financing Cash Flow | $6M | $13M | $58M | $16M | $109M | $94M | |
| Net Change in Cash | $-54M | $-43M | $25M | $-28M | $66M | $75M | |
| Free Cash Flow | $-60M | $-56M | $-33M | $-44M | $-43M | · |
Profitabilitas 2
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -62.0% | -46.7% | -22.3% | -31.7% | -36.3% | · | |
| ROE | -183.6% | -86.6% | -33.4% | -42.5% | -31.0% | · |
Likuiditas & Solvabilitas 4
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 7.4 | 7.1 | 5.8 | 13.6 | · | |
| Quick Ratio | 1.6 | 7.3 | 6.9 | 5.4 | 13.3 | · | |
| Debt / Equity | 1.1 | 0.0 | 0.1 | · | · | · | |
| Interest Coverage | · | · | -12.9 | · | · | · |
Valuasi (TTM) 11
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-61M | $-71M | $-37M | $-54M | $-50M | · | |
| Market Cap | $31M | $66M | $151M | $64M | $325M | · | |
| Enterprise Value | $2M | $-45M | $23M | · | · | · | |
| P/E | -0.5 | -0.9 | -3.7 | -1.1 | -1.1 | · | |
| P/B | 1.2 | 0.9 | 1.4 | 0.5 | 2.1 | · | |
| P / Tangible Book | 1.2 | 0.9 | 1.4 | 0.5 | 2.1 | · | |
| P / Cash Flow | -0.5 | -1.2 | -4.6 | -1.6 | -7.6 | · | |
| P / FCF | -0.5 | -1.2 | -4.5 | -1.5 | -7.5 | · | |
| EV / EBITDA | -0.0 | 0.6 | -0.6 | · | · | · | |
| EV / FCF | -0.0 | 0.8 | -0.7 | · | · | · | |
| Earnings Yield | -209.8% | -110.1% | -27.2% | -90.7% | -91.9% | · |
Laporan Laba Rugi 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $8M | $7M | $12M | $13M | $13M | $16M | $13M | $15M | $13M | $10M | $11M | $10M | $12M | $16M | $13M | |
| SG&A Expense | $8M | $5M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $4M | |
| Operating Expenses | $14M | $13M | $9M | $16M | $18M | $18M | $20M | $17M | $20M | $18M | $14M | $15M | $14M | $17M | $20M | $18M | |
| Operating Income | $7M | $-13M | $-9M | $-16M | $-18M | $-18M | $-20M | $-17M | $-19M | $-17M | $-13M | $-9M | $-6M | $-12M | $-13M | $-13M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | · | · | · | $172.0K | · | · | |
| Interest Income | $277.0K | $433.0K | $564.0K | $697.0K | $850.0K | $997.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | |
| Other Non-op | $64.0K | $674.0K | $2M | $0 | $11.0K | $168.0K | $-94.0K | $97.0K | $2M | $-1.0K | $-6.0K | $-5.0K | $-25.0K | $-1M | $70.0K | $3.0K | |
| Net Income | $4M | $-14M | $-8M | $-16M | $-18M | $-18M | $-20M | $-17M | $-17M | $-16M | $-12M | $-8M | $-5M | $-12M | $-12M | $-12M | |
| EPS (Basic) | $0.08 | $-0.28 | $-0.16 | $-0.36 | $-0.40 | $-0.40 | $-0.46 | $-0.38 | $-0.40 | $-0.39 | $-0.34 | $-0.23 | $-0.14 | $-0.34 | $-0.37 | $-0.40 | |
| EPS (Diluted) | $0.08 | $-0.28 | $-0.17 | $-0.36 | $-0.40 | $-0.40 | $-0.43 | $-0.38 | $-0.43 | $-0.39 | $-0.34 | $-0.23 | $-0.14 | $-0.34 | $-0.37 | $-0.40 | |
| Shares (Basic) | 48,597,534 | 48,596,817 | -89,594,059 | 45,804,042 | 44,981,746 | 44,827,159 | -85,501,433 | 43,704,836 | 43,521,406 | 41,607,279 | -70,349,735 | 35,653,924 | 35,557,701 | 34,784,682 | -55,810,065 | 29,764,000 | |
| Shares (Diluted) | 48,597,534 | 49,388,181 | -88,802,695 | 45,804,042 | 44,981,746 | 44,827,159 | -85,495,635 | 43,704,836 | 44,043,184 | 41,607,279 | -70,349,735 | 35,653,924 | 35,557,701 | 34,784,682 | -55,810,065 | 29,764,000 | |
| EBITDA | $7M | $-13M | · | $-16M | $-18M | $-18M | · | $-17M | $-19M | $-17M | · | $-9M | $-6M | $-12M | · | $-13M |
Neraca 23
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $22M | $46M | $57M | $66M | $78M | $92M | $111M | $123M | $135M | $139M | $134M | $130M | $137M | $148M | $129M | $140M | |
| Prepaid Expense | $905.0K | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $4M | $7M | |
| Current Assets | $23M | $49M | $59M | $68M | $80M | $94M | $113M | $126M | $139M | $142M | $138M | $139M | $147M | $157M | $140M | $152M | |
| PP&E (Net) | $1M | $4M | $5M | $5M | $5M | $6M | $6M | $7M | $7M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | |
| PP&E (Gross) | · | · | $11M | · | · | · | $11M | · | · | · | $11M | · | · | · | $10M | $10M | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $992.0K | |
| Other Non-current Assets | $0 | $0 | $5.0K | $46.0K | $122.0K | $179.0K | $320.0K | $42.0K | $265.0K | $248.0K | $594.0K | $516.0K | $652.0K | $670.0K | $1M | $2M | |
| Total Assets | $24M | $58M | $69M | $80M | $93M | $107M | $127M | $140M | $154M | $178M | $175M | $176M | $185M | $195M | $160M | $172M | |
| Accounts Payable | $2M | $4M | $754.0K | $1M | $3M | $986.0K | $3M | $1M | $1M | $2M | $1M | $1M | $1M | $2M | $1M | $1M | |
| Accrued Liabilities | $6M | $5M | $5M | $9M | $9M | $9M | $11M | $10M | $9M | $6M | $9M | $8M | $10M | $13M | $14M | $14M | |
| Short-term Debt | $0 | $29M | $28M | $6M | $2M | · | $0 | $0 | $0 | $12M | $7M | $2M | · | · | $0 | · | |
| Current Liabilities | $8M | $39M | $36M | $18M | $15M | $12M | $15M | $12M | $11M | $21M | $19M | $14M | $15M | $22M | $24M | $28M | |
| Capital Leases | $0 | $7M | $8M | $8M | $9M | $9M | $9M | $10M | $10M | $11M | $11M | $11M | $12M | $12M | $13M | $13M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $191.0K | $191.0K | |
| Total Liabilities | $8M | $46M | $45M | $50M | $51M | $50M | $54M | $51M | $50M | $60M | $63M | $64M | $67M | $74M | $38M | $41M | |
| Long-term Debt | · | $32M | $32M | $32M | $32M | $32M | · | $32M | $32M | $40M | · | · | · | · | · | · | |
| Total Debt | $0 | $29M | · | $6M | $2M | · | · | $0 | $0 | $12M | · | $2M | · | · | · | · | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Paid-in Capital | $502M | $501M | $500M | $497M | $492M | $490M | $488M | $484M | $482M | $478M | $455M | $445M | $442M | $440M | $429M | $426M | |
| Retained Earnings | $-485M | $-489M | $-475M | $-467M | $-451M | $-433M | $-415M | $-394M | $-378M | $-360M | $-344M | $-332M | $-324M | $-319M | $-307M | $-295M | |
| Stockholders' Equity | $16M | $12M | $25M | $30M | $41M | $57M | $73M | $89M | $104M | $118M | $111M | $112M | $119M | $121M | $122M | $131M | |
| Liabilities + Equity | $24M | $58M | $69M | $80M | $93M | $107M | $127M | $140M | $154M | $178M | $175M | $176M | $185M | $195M | $160M | $172M | |
| Shares Outstanding | 48,599,066 | 48,596,817 | 48,596,817 | 47,273,685 | 45,335,265 | 44,827,159 | 44,827,159 | 43,721,772 | 43,702,147 | 43,282,371 | 39,107,048 | 35,658,000 | 35,642,000 | 35,301,000 | 31,433,731 | 30,611,000 |
Arus Kas 9
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $419.0K | $929.0K | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $7M | $-11M | $-11M | $-15M | $-15M | $-19M | $-14M | $-12M | $-14M | $-15M | $-5M | $-7M | $-11M | $-10M | $-12M | $-14M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $123.0K | $3.0K | $17.0K | $111.0K | $198.0K | $221.0K | $182.0K | $168.0K | $518.0K | $2M | |
| Investing Cash Flow | · | · | $0 | $0 | $0 | $0 | $-123.0K | $-3.0K | $-17.0K | $-111.0K | $-198.0K | $-221.0K | $-182.0K | $-168.0K | $-518.0K | $-2M | |
| Stock Issued | · | · | $2M | $3M | $347.0K | $0 | $2M | $-29.0K | $877.0K | $20M | $9M | $-84.0K | $552.0K | $9M | $979.0K | $11M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $20M | · | · | · | $9M | · | · | |
| Financing Cash Flow | · | · | $2M | $3M | $388.0K | $0 | $3M | $-6.0K | $-10M | $20M | $9M | $41.0K | $692.0K | $49M | $1M | $11M | |
| Net Change in Cash | $-25M | $-11M | $-9M | $-12M | $-15M | $-19M | $-12M | $-12M | $-24M | $5M | $4M | $-7M | $-10M | $39M | $-11M | $-5M | |
| Free Cash Flow | · | · | · | · | · | $-19M | · | · | · | $-15M | · | · | · | $-10M | · | · |
Profitabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 6.3% | -16.4% | · | -14.9% | -14.6% | -12.7% | · | -10.5% | -10.2% | -8.7% | · | -4.8% | -2.8% | -6.7% | · | -6.8% | |
| ROE | 12.7% | -38.9% | · | -27.5% | -24.7% | -20.7% | · | -16.5% | -15.5% | -13.6% | · | -6.8% | -4.1% | -9.2% | · | -8.0% |
Likuiditas & Solvabilitas 4
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 1.3 | · | 3.9 | 5.3 | 8.1 | · | 10.1 | 12.1 | 6.7 | · | 9.6 | 9.8 | 7.2 | · | 5.5 | |
| Quick Ratio | 2.8 | 1.2 | · | 3.7 | 5.1 | 7.9 | · | 9.9 | 11.8 | 6.6 | · | 9.0 | 9.2 | 6.8 | · | 5.1 | |
| Debt / Equity | 0.0 | 2.4 | · | 0.2 | 0.1 | · | · | 0.0 | 0.0 | 0.1 | · | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -17.1 | · | · | · | · | · | · |
Valuasi (TTM) 11
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-44M | $-66M | · | $-69M | $-70M | $-68M | · | $-58M | $-47M | $-42M | · | $-37M | $-44M | $-54M | · | $-56M | |
| Market Cap | $17M | $40M | · | $93M | $49M | $44M | · | $93M | $107M | $280M | · | $76M | $109M | $92M | · | $138M | |
| Enterprise Value | $-4M | $23M | · | $33M | $-26M | · | · | $-30M | $-29M | $153M | · | $-52M | · | · | · | · | |
| P/E | -0.4 | -0.6 | · | -1.3 | -0.7 | -0.6 | · | -1.5 | -2.1 | -5.9 | · | -1.9 | -2.2 | -1.4 | · | -2.3 | |
| P/B | 1.1 | 3.3 | · | 3.1 | 1.2 | 0.8 | · | 1.0 | 1.0 | 2.4 | · | 0.7 | 0.9 | 0.8 | · | 1.1 | |
| P / Tangible Book | 1.1 | 3.3 | · | 3.1 | 1.2 | 0.8 | · | 1.0 | 1.0 | 2.4 | · | 0.7 | 0.9 | 0.8 | · | 1.1 | |
| P / Cash Flow | · | -3.8 | · | · | · | -2.3 | · | · | · | -18.3 | · | · | · | -9.3 | · | · | |
| P / FCF | · | · | · | · | · | -2.3 | · | · | · | -18.2 | · | · | · | -9.1 | · | · | |
| EV / EBITDA | -0.6 | -1.7 | · | -2.1 | 1.5 | · | · | 1.8 | 1.5 | -8.9 | · | 5.6 | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -9.9 | · | · | · | · | · | · | |
| Earnings Yield | -266.7% | -172.9% | · | -78.2% | -147.7% | -164.6% | · | -67.5% | -48.8% | -17.0% | · | -51.9% | -46.2% | -70.4% | · | -44.4% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Laba Bersih | $-61M | $-71M | $-37M | $-54M | $-50M |
| EPS Dilusian | $-1.33 | $-1.63 | $-1.05 | $-1.86 | $-10.94 |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Utang / Ekuitas | 1.1 | 0.0 | 0.1 | — | — |
| Rasio Lancar | 1.6 | 7.4 | 7.1 | 5.8 | 13.6 |
| Rasio Cepat | 1.6 | 7.3 | 6.9 | 5.4 | 13.3 |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-60M | $-56M | $-33M | $-44M | $-43M |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 54 pengaju · $12.4M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 13 (+3 vs Kuartal sebelumnya) | 11 (0 vs Kuartal sebelumnya) | 9 (+2 vs Kuartal sebelumnya) | 8 (-3 vs Kuartal sebelumnya) | -3.3M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | $8.490.424 | 4.309.860 | 68,38% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $859.349 | 2.387.744 | 6,92% | Saham |
| Balyasny Asset Management L.P. | $644.253 | 1.790.089 | 5,19% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $438.471 | 1.217.976 | 3,53% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $242.800 | 674.632 | 1,96% | Saham |
| Lynx1 Capital Management LP | $236.737 | 657.786 | 1,91% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $225.589 | 626.810 | 1,82% | Saham |
| DC Funds, LP | $212.018 | 589.102 | 1,71% | Saham |
| Verdad Advisers, LP | $125.500 | 348.709 | 1,01% | Saham |
| VANGUARD GROUP INC | $113.948 | 179.728 | 0,92% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $98.563 | 273.764 | 0,79% | Saham |
| XTX Topco Ltd | $97.705 | 271.478 | 0,79% | Saham |
| Cubist Systematic Strategies, LLC | $92.020 | 46.711 | 0,74% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $56.781 | 157.726 | 0,46% | Saham |
| JANE STREET GROUP, LLC | $52.752 | 146.573 | 0,42% | Saham |
| STATE STREET CORP | $42.889 | 119.168 | 0,35% | Saham |
| Squarepoint Ops LLC | $37.157 | 103.242 | 0,30% | Saham |
| Rangeley Capital, LLC | $35.990 | 100.000 | 0,29% | Saham |
| Nuveen Asset Management, LLC | $31.557 | 21.322 | 0,25% | Saham |
| NORTHERN TRUST CORP | $31.258 | 86.851 | 0,25% | Saham |
| Alyeska Investment Group, L.P. | $31.151 | 86.554 | 0,25% | Saham |
| MPM BIOIMPACT LLC | $28.851 | 80.142 | 0,23% | Saham |
| CITADEL ADVISORS LLC | $26.993 | 75.000 | 0,22% | Opsi beli |
| Point72 Asia (Singapore) Pte. Ltd. | $25.642 | 13.016 | 0,21% | Saham |
| MILLENNIUM MANAGEMENT LLC | $22.334 | 62.055 | 0,18% | Saham |
| H D Vest Advisory Services | $11.118 | 10.200 | 0,09% | Saham |
| BlackRock, Inc. | $10.661 | 29.623 | 0,09% | Saham |
| TWO SIGMA INVESTMENTS, LP | $9.825 | 27.300 | 0,08% | Saham |
| StoneX Group Inc. | $9.000 | 20.000 | 0,07% | Saham |
| BANK OF AMERICA CORP /DE/ | $8.331 | 23.206 | 0,07% | Saham |
| GOLDMAN SACHS GROUP INC | $7.206 | 20.023 | 0,06% | Saham |
| TWO SIGMA ADVISERS, LP | $6.525 | 10.300 | 0,05% | Saham |
| CITADEL ADVISORS LLC | $5.578 | 15.500 | 0,04% | Opsi jual |
| CERTUITY, LLC | $5.399 | 15.000 | 0,04% | Saham |
| HBK Sorce Advisory LLC | $5.317 | 13.227 | 0,04% | Saham |
| BARCLAYS PLC | $4.763 | 13.235 | 0,04% | Saham |
| Larson Financial Group LLC | $4.697 | 13.052 | 0,04% | Saham |
| LPL Financial LLC | $4.244 | 11.791 | 0,03% | Saham |
| Ranch Capital Advisors Inc. | $3.959 | 11.000 | 0,03% | Saham |
| Marest Capital, LLC | $3.912 | 10.870 | 0,03% | Saham |
| Cetera Investment Advisers | $3.671 | 10.200 | 0,03% | Saham |
| Tower Research Capital LLC (TRC) | $3.562 | 9.897 | 0,03% | Saham |
| OSAIC HOLDINGS, INC. | $3.087 | 8.575 | 0,02% | Saham |
| Financial Perspectives, Inc | $2.429 | 6.750 | 0,02% | Saham |
| MORGAN STANLEY | $678 | 1.885 | 0,01% | Saham |
| GROUP ONE TRADING LLC | $673 | 1.871 | 0,01% | Saham |
| JPMORGAN CHASE & CO | $287 | 931 | 0,00% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $284 | 790 | 0,00% | Saham |
| SIMPLEX TRADING, LLC | $91 | 255 | 0,00% | Saham |
| UBS Group AG | $37 | 102 | 0,00% | Saham |
| SBI Securities Co., Ltd. | $36 | 100 | 0,00% | Saham |
| Virtu Financial LLC | $16 | 45.467 | 0,00% | Saham |
| GSA CAPITAL PARTNERS LLP | $10 | 27.146 | 0,00% | Saham |
| Optiver Holding B.V. | $8 | 22 | 0,00% | Saham |
Orang dalam perusahaan 20 orang dalam · 6 pejabat · 10 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Daniel J Hicklin | President and Chief Executive Officer | 2 Jan. 2025 A | — | 0 | 0 | $0 |
| Timothy W. Trost | Chief Financial Officer | 2 Jan. 2025 A | — | 0 | 0 | $0 |
| Chulani Karunatilake | Chief Technology Officer | 2 Jan. 2025 A | — | 0 | 0 | $0 |
| Ellen Lubman | Chief Business Officer | 2 Jan. 2025 A | — | 0 | 0 | $0 |
| Randi Isaacs | Chief Medical Officer | 2 Jan. 2025 A | — | 0 | 0 | $0 |
| Cynthia Seidel-Dugan | Chief Scientific Officer | 2 Jan. 2024 A | 164.888 | 0 | 0 | $0 |
| Luke Evnin | Direktur | 7 Juli 2026 S | 0 | 0 | 87 | $-3.255.563 |
| Michael B. Atkins | Direktur | 12 Juni 2025 A | — | 0 | 0 | $0 |
| Anil K. Singhal | Direktur | 12 Juni 2025 A | — | 0 | 0 | $0 |
| Meeta Chatterjee | Direktur | 12 Juni 2025 A | — | 0 | 0 | $0 |
| Alon Lazarus | Direktur | 12 Juni 2025 A | 2.046.634 | 0 | 0 | $0 |
| Briggs Morrison | Direktur | 12 Juni 2025 A | — | 0 | 0 | $0 |
| Michael A. Sherman | Direktur | 12 Juni 2025 A | — | 0 | 0 | $0 |
| Derek Dirocco | Direktur | 24 Mei 2024 A | — | 0 | 0 | $0 |
| Sakae Asanuma | Direktur | 4 Mei 2021 C | 2.068.909 | 0 | 0 | $0 |
| Taiho Ventures LLC | Pemilik 10% | 4 Mei 2021 C | 2.068.909 | 0 | 0 | $0 |
| UPMC | Pemilik 10% | 4 Mei 2021 C | 1.097.756 | 0 | 0 | $0 |
| HBM Healthcare Investments (Cayman) Ltd. | Pemilik 10% | 4 Mei 2021 C | 625.995 | 0 | 0 | $0 |
| Steven H. Bloom | — | 1 Mei 2025 A | — | 0 | 0 | $0 |
| Reid Leonard | — | 3 Jan. 2023 A | 14.102 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×13 pengajuan | 2 Juli 2026 | 4,10% | Amandemen | — | SEC |
| MPM BioVentures 2014, L.P., MPM BioVentures 2014 (B), L.P., MPM Asset Management Investors BV2014 LLC, UBS Oncology Impact Fund L.P., MPM BioVentures 2014 GP LLC, MPM BioVentures 2014 LLC, Oncology Impact Fund (Cayman) Management L.P., MPM BioImpact LLC, ANSBERT GADICKE, LUKE EVNIN, Todd Foley, MPM ASSET MANAGEMENT LLC, MPM ONCOLOGY INNOVATIONS FUND LP, MPM Oncology Innovations Fund GP LLC ×8 pengajuan | 12 Mei 2026 | 3,80% | Amandemen | — | SEC |
| Taiho Ventures LLC | 13 Mei 2021 | — | Pengajuan awal | Kampanye dewan | SEC |
| Arkin Bio Ventures 2 L.P., Arkin Bio Venture GPGP Ltd., Moshe Arkin, Alon Lazarus | 10 Mei 2021 | — | Pengajuan awal | Kampanye dewan | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 2 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.